A Phase III Study to Evaluate the Efficacy and Safety of Proxalutamide (GT0918) in Hospitalized Subjects with COVID-19
Clinical Trial Grant
Administered By
Institutes and Centers
Awarded By
Suzhou Kintor Pharmaceuticals, Inc.
Start Date
October 31, 2022
End Date
November 14, 2022
Administered By
Institutes and Centers
Awarded By
Suzhou Kintor Pharmaceuticals, Inc.
Start Date
October 31, 2022
End Date
November 14, 2022